Comparison between sodium-glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta-analysis.

Yun Kyung ChoYe-Jee KimYu Mi KangSeung Eun LeeJoong-Yeol ParkWoo Je LeeChang Hee Jung

Published in: Journal of diabetes investigation (2018)

Both PIO and SGLT2i are feasible adjunctive oral agents to pre-existing insulin therapy in individuals with inadequately controlled type 2 diabetes mellitus.

Keyphrases

type diabetes
glycemic control
systematic review
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular disease
prognostic factors
stem cells
patient reported outcomes
adipose tissue
weight loss
mesenchymal stem cells